Status: Recruiting
Integrative Diagnosis for SCD and Other RADs
INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and genetic characterization through combining new generation methodologies.
Participants needed: 200
Trial details
Biological sex: AllType: ObservationalSponsor: Hospital Universitari Vall d'Hebron Research InstituteUpdated: Oct 3, 2025Locations: 9
Eligibility criteria
Sickle cell disease [+9]
Carrier traits in autosomal recessive hereditary anemias